Priya Singhal
CIK 1769608 · Head of Development · last filed 2026-02-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.76M
Companies
2
Total Filings
42
Lifetime Open-Market Net
-$2.02M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIIB | Head of Development | 8,488 | $207.74 | $1.76M | -$2.02M | 27 | 2026-02-17 |
| Larimar Therapeutics, Inc. (ZFGN) Delisted | Head of Research & Development | — | — | — | $0 | 1 | 2019-04-04 |
Recent Filings · Page 4 of 5
42 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-09-06 | BIIB | Mixed | +430 | -$331.7K | EDGAR |
| 2023-09-05 | BIIB | Notice (144) | −431 | -$116.1K | EDGAR |
| 2023-07-05 | BIIB | Mixed | +81 | -$66.5K | EDGAR |
| 2023-07-03 | BIIB | Notice (144) | −81 | -$22.9K | EDGAR |
| 2023-04-06 | BIIB | Sell (S) | −91 | -$25.2K | EDGAR |
| 2023-03-30 | BIIB | Sell (S) | −568 | -$153.4K | EDGAR |
| 2023-03-06 | BIIB | Mixed | −390 | -$184.6K | EDGAR |
| 2023-02-22 | BIIB | Mixed | +309 | -$42.0K | EDGAR |
| 2023-02-14 | BIIB | Mixed | +839 | -$106.5K | EDGAR |
| 2023-02-03 | BIIB | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.